Skin Cancer Diagnostics Market Master Unit Subscriber Connector Forecast Year 2028

According to a new research report published by Premium Market Insights, “  The skin cancer diagnostics market  is projected to reach $5,480.45 million by 2028, up from $3,364.46 million in 2021. 2021-2028. The report highlights the prevailing trends in the market and the factors driving growth. The growth of the market is attributed to the increasing incidence of skin cancer and the launch of new products. Income countries impede market growth.

Get PDF sample at 

The surge in awareness is largely due to the support provided by various governments through awareness and prevention campaigns. The Centers for Disease Control and Prevention (CDC) and its partners monitor skin cancer cases, conduct research, and provide education and intervention about skin cancer. Monitoring is done through national surveys such as the Youth Risk Behavior Surveillance System and the National Health Interview Survey. This survey helps assess the prevalence of sunburn and sun protection behaviors that help prevent skin cancer. Countries such as the UK and the Netherlands have also taken initiatives to promote early diagnosis of skin cancer. In 2007, an early detection program was launched at Cancer Research UK. As part of the UK’s National Awareness and Early Diagnosis Initiative (NAEDI). Similarly, the Skin Cancer Prevention Strategy and Action Plan (2011-2021) was launched in Northern Ireland in July 2011, with a focus on skin cancer prevention and early detection in the region. Therefore, government efforts to control skin cancer-related mortality will provide significant opportunities for skin cancer diagnostics market players in the coming years.

Inquire before purchase  :

Based on type, the global skin cancer diagnostics market has been segmented into melanoma and non-melanoma. The non-melanoma segment accounted for the largest share of the market in 2021 and is expected to register the highest CAGR in the market during the forecast period. Based on screening type, the market is segmented into blood tests, dermatoscopy, imaging tests, lymph node biopsies, and skin biopsies. The skin biopsy segment held the largest share of the market in 2021 and is expected to register a high CAGR in the market during the forecast period.

Some major primary and secondary sources mentioned while preparing the report on skin cancer diagnostics market are National Center for Health Statistics, Medical Research Council of India, Centers for Disease Control and Prevention (CDC), and National Center for Biotechnology. Information (NCBI) and World Health Organization.

Order a copy of the research study at 

About Us:

Premium Market Insights is a one-stop shop for market research reports and solutions for various companies worldwide. We help our clients’ decision support systems by helping them select the most appropriate and cost-effective research reports and solutions from a variety of publishers.

The market research industry has changed over the past decade. As corporate focus shifts to niche markets and emerging countries, many publishers have stepped in to meet this information need. We have experienced and trained staff to help you explore different options and select the best research solution at the most effective cost.

Premium Market Insights offers a wide range of industry reports, company reports and country reports for all industries. If syndicated reports from major publishers do not meet your research needs, we can contact various research institutions to provide you with customized research solutions, saving you valuable time and money.

We offer best-in-class customer service and our customer support team is always available to help with your research questions. Our commitment to customer service is best demonstrated in the free analyst support we provide to our clients that sets us apart from other providers. We also offer Enterprise Subscriptions that offer significant cost savings to our customers.

 Contact Us:

Contact Person: Sameer Joshi

Phone: +1-646-491-9876

Email ID: [email protected]